Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.120
+0.050 (1.23%)
At close: Oct 2, 2026, 4:00 PM EDT
4.125
+0.005 (0.12%)
After-hours: Oct 2, 2026, 7:58 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.21 billion as of October 2, 2026. Its market cap has decreased by -0.88% in one year.
Market Cap
2.21B
Enterprise Value
1.73B
1-Year Change
-0.88%
Ranking
Category
Stock Price
$4.12
ChartMarket Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.21B, a decrease of -56.47%. That is a compound annual growth rate of -14.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.21B | 3.79% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.30B |
| SELLAS Life Sciences Group | 2.29B |
| Vera Therapeutics | 2.23B |
| ADMA Biologics | 2.22B |
| Pharvaris | 2.18B |
| Viridian Therapeutics | 2.15B |
| Aurinia Pharmaceuticals | 2.12B |
| Mineralys Therapeutics | 2.10B |